30 March 2018
: Case report
Atypical Presentation of Gelsolin Amyloidosis in a Man of African Descent with a Novel Mutation in the Gelsolin Gene
Challenging differential diagnosis, Rare disease
Karlos Z. Oregel1EF, Geoffrey P. Shouse1ABCDEF*, Cyrus Oster2E, Freddy Martinez3BE, Jun Wang4E, Michael Rosenzweig5E, Jeremy K. Deisch4BCD, Chien-Shing Chen1E, Gayathri Nagaraj1EDOI: 10.12659/AJCR.907550
Am J Case Rep 2018; 19:374-381
Abstract
BACKGROUND: Gelsolin amyloidosis is a very rare systemic disease presenting with a pathognomonic triad of corneal lattice dystrophy, cutis laxa, and polyneuropathy. The disease is mostly restricted to a Finnish population with known mutations (G654A, G654T) in exon 4 of the gelsolin gene. The mutations lead to errors in protein processing and folding, and ultimately leads to deposition of an amyloidogenic fragment in the extracellular space, causing the symptoms of disease.
CASE REPORT: We present a case of gelsolin amyloidosis in a male of African descent with an atypical clinical presentation including fevers, skin rash, polyneuropathy, and anemia. Gelsolin amyloidosis was diagnosed based on mass spectrometry of tissue samples. Importantly, a novel mutation in the gelsolin gene (C1375G) in exon 10 was found in this patient. His atypical presentation can possibly be attributed to the presence of a novel mutation in the gelsolin gene as the likely underlying cause of the syndrome. PCR primers were used to amplify the gelsolin gene from genomic DNA. Purified PCR products were then shipped to Eton Biosciences (San Diego, CA) for sequencing.
CONCLUSIONS: This study carries several important lessons relevant to the practice of medicine. First, the differential diagnosis for multisystem disease presentations should always include amyloidosis. Second, despite what has been uncovered about the molecular biology of disease, there is always more that can be discovered. Finally, further work to verify the link between this mutation and the clinical syndrome is still needed, as are effective treatments for this disease.
Keywords: Amyloid Neuropathies, Familial, Amyloidosis, Familial, Gelsolin
SARS-CoV-2/COVID-19
11 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936496
09 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937505
29 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937105
08 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937212
In Press
17 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936537
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937511
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937598
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936743
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399